253 related articles for article (PubMed ID: 33137879)
1. Effects of 3-Month Exposure to E-Cigarette Aerosols on Glutamatergic Receptors and Transporters in Mesolimbic Brain Regions of Female C57BL/6 Mice.
Alhaddad H; Wong W; Sari AT; Crotty Alexander LE; Sari Y
Toxics; 2020 Oct; 8(4):. PubMed ID: 33137879
[TBL] [Abstract][Full Text] [Related]
2. Peri-adolescent drinking of ethanol and/or nicotine modulates astroglial glutamate transporters and metabotropic glutamate receptor-1 in female alcohol-preferring rats.
Alasmari F; Bell RL; Rao PSS; Hammad AM; Sari Y
Pharmacol Biochem Behav; 2018 Jul; 170():44-55. PubMed ID: 29753887
[TBL] [Abstract][Full Text] [Related]
3. Effects of Chronic Hydrocodone Exposure and Ceftriaxone on the Expression of Astrocytic Glutamate Transporters in Mesocorticolimbic Brain Regions of C57/BL Mice.
Wong W; Sari Y
Toxics; 2023 Oct; 11(10):. PubMed ID: 37888720
[TBL] [Abstract][Full Text] [Related]
4. Effects of a Novel Beta Lactam Compound, MC-100093, on the Expression of Glutamate Transporters/Receptors and Ethanol Drinking Behavior of Alcohol-Preferring Rats.
Alhaddad H; Wong W; Abou-Gharbia M; Childers W; Melenski E; Bell RL; Sari Y
J Pharmacol Exp Ther; 2022 Dec; 383(3):208-216. PubMed ID: 36153003
[TBL] [Abstract][Full Text] [Related]
5. Effects of Hydrocodone Overdose and Ceftriaxone on Astrocytic Glutamate Transporters and Glutamate Receptors, and Associated Signaling in Nucleus Accumbens as well as Locomotor Activity in C57/BL Mice.
Wong W; Sari Y
Brain Sci; 2024 Apr; 14(4):. PubMed ID: 38672013
[TBL] [Abstract][Full Text] [Related]
6. Effects of novel beta-lactam, MC-100093, and ceftriaxone on astrocytic glutamate transporters and neuroinflammatory factors in nucleus accumbens of C57BL/6 mice exposed to escalated doses of morphine.
Sari Y; Swiss GMS; Alrashedi FA; Baeshen KA; Alshammari SA; Alsharari SD; Ali N; Alasmari AF; Alhoshani A; Alameen AA; Childers WE; Abou-Gharbia M; Alasmari F
Saudi Pharm J; 2024 Jul; 32(7):102108. PubMed ID: 38868175
[TBL] [Abstract][Full Text] [Related]
7. Differential Toxicity of Electronic Cigarette Aerosols Generated from Different Generations of Devices
Ma T; Chen H; Liao YP; Li J; Wang X; Li L; Li J; Zhu Y; Xia T
Environ Health (Wash); 2023 Nov; 1(5):315-323. PubMed ID: 38028320
[TBL] [Abstract][Full Text] [Related]
8. Isolation of RNA from the Murine Colonic Tissue and qRT-PCR for Inflammatory Cytokines.
Sayed IM; Inouye K; Das S; Alexander LC
Bio Protoc; 2023 Mar; 13(6):e4634. PubMed ID: 36968437
[TBL] [Abstract][Full Text] [Related]
9. Clearing the Haze: What Do We Still Need to Learn about Electronic Nicotine Delivery Systems?
Fucito LM; Malinosky H; Baldassarri SR; Herbst RS
Cancer Prev Res (Phila); 2021 Jan; 14(1):5-10. PubMed ID: 33148678
[TBL] [Abstract][Full Text] [Related]
10. E-cigarette use is associated with subsequent cigarette use among young adult non-smokers, over and above a range of antecedent risk factors: a propensity score analysis.
Epstein M; Bailey JA; Kosterman R; Rhew IC; Furlong M; Oesterle S; McCabe SE
Addiction; 2021 May; 116(5):1224-1232. PubMed ID: 33140475
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity and Genotoxicity of E-Cigarette Generated Aerosols Containing Diverse Flavoring Products and Nicotine in Oral Epithelial Cell Lines.
Tellez CS; Juri DE; Phillips LM; Do K; Yingling CM; Thomas CL; Dye WW; Wu G; Kishida S; Kiyono T; Belinsky SA
Toxicol Sci; 2021 Jan; 179(2):220-228. PubMed ID: 33226417
[TBL] [Abstract][Full Text] [Related]
12. Electronic cigarette aerosols induce oxidative stress-dependent cell death and NF-κB mediated acute lung inflammation in mice.
Ma T; Wang X; Li L; Sun B; Zhu Y; Xia T
Arch Toxicol; 2021 Jan; 95(1):195-205. PubMed ID: 33159582
[TBL] [Abstract][Full Text] [Related]
13. How effective are electronic cigarettes for reducing respiratory and cardiovascular risk in smokers? A systematic review.
Goniewicz ML; Miller CR; Sutanto E; Li D
Harm Reduct J; 2020 Nov; 17(1):91. PubMed ID: 33228671
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo cardiac toxicity of flavored electronic nicotine delivery systems.
Abouassali O; Chang M; Chidipi B; Martinez JL; Reiser M; Kanithi M; Soni R; McDonald TV; Herweg B; Saiz J; Calcul L; Noujaim SF
Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H133-H143. PubMed ID: 33216635
[TBL] [Abstract][Full Text] [Related]
15. Smoking Intention and Progression From E-Cigarette Use to Cigarette Smoking.
Owotomo O; Stritzel H; McCabe SE; Boyd CJ; Maslowsky J
Pediatrics; 2020 Dec; 146(6):. PubMed ID: 33168672
[TBL] [Abstract][Full Text] [Related]
16. Acute effects of electronic cigarettes on arterial pressure and peripheral sympathetic activity in young nonsmokers.
Gonzalez JE; Cooke WH
Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H248-H255. PubMed ID: 33164580
[TBL] [Abstract][Full Text] [Related]
17. E-cigarette use and respiratory disorders: an integrative review of converging evidence from epidemiological and laboratory studies.
Wills TA; Soneji SS; Choi K; Jaspers I; Tam EK
Eur Respir J; 2021 Jan; 57(1):. PubMed ID: 33154031
[TBL] [Abstract][Full Text] [Related]
18. Electronic Cigarettes: Past, Present, and Future: What Clinicians Need to Know.
Baldassarri SR
Clin Chest Med; 2020 Dec; 41(4):797-807. PubMed ID: 33153696
[TBL] [Abstract][Full Text] [Related]
19. Examining electronic nicotine delivery system use and perception of use among college students with and without asthma across the South.
Gibson-Young L; Martinasek M; Tamulevicius N; Fortner M; Alanazi AM
J Am Coll Health; 2022 Oct; 70(7):2026-2032. PubMed ID: 33151831
[No Abstract] [Full Text] [Related]
20. E-cigarette or vaping product use-associated lung injury (EVALI) features and recognition in the emergency department.
Aldy K; Cao DJ; Weaver MM; Rao D; Feng SY
J Am Coll Emerg Physicians Open; 2020 Oct; 1(5):1090-1096. PubMed ID: 33145562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
